Home › Ovarian Cancer › Michigan › Muskegon
Ovarian Cancer clinical trials in Muskegon, MI
3 studies for Ovarian Cancer are looking for participants at sites in and around Muskegon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Trinity Health Muskegon Hospital, Muskegon
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Trinity Health Muskegon Hospital, Muskegon
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Trinity Health Muskegon Hospital, Muskegon
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX90 studies
- New York City, NY75 studies
- Boston, MA62 studies
- Los Angeles, CA53 studies
- Nashville, TN50 studies
- Arlington, VA47 studies
- Philadelphia, PA47 studies
- Columbus, OH39 studies
- St. Louis, MO37 studies
- Chicago, IL36 studies
- San Antonio, TX33 studies
- Pittsburgh, PA32 studies
Other studies in Muskegon
- Melanoma3 studies
- Non-Small Cell Lung Cancer3 studies
- Colorectal Cancer3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.